Functional amyloidogenesis and cytotoxicity-insights into biology and pathology

Douglas M Fowler1, Jeffery W Kelly

  • 1Department of Genome Sciences, University of Washington, Seattle, Washington, USA. dfowler@uw.edu

Plos Biology
|January 10, 2013
PubMed

Insights

Prions like [Het-s] in fungi cause cell death by forming amyloid aggregates. This study reveals how [Het-s] amyloid triggers a conformational change in Het-S protein, leading to membrane pore formation and cell death.

Area of Science:

  • Mycology
  • Structural Biology
  • Cell Biology

Background:

  • Prions are self-templating proteins capable of inter-organismal transfer.
  • The [Het-s] prion in Podospora anserina is a functional amyloid involved in heterokaryon incompatibility.
  • Incompatibility involves cell death upon fusion of [Het-s] prion strains with Het-S expressing strains.

Purpose of the Study:

  • To elucidate the mechanism of cell death mediated by the [Het-s] prion and Het-S protein interaction.
  • To understand how functional amyloid aggregates initiate cytotoxicity.

Main Methods:

  • Investigated the structural and functional consequences of [Het-s] and Het-S C-terminal domain co-amyloidogenesis.
  • Analyzed conformational changes in the Het-S protein, including N-terminal HeLo domain rearrangements.
  • Examined the formation of transmembrane helices and subsequent pore formation.

Main Results:

  • Co-amyloidogenesis of Het-s and Het-S C-terminal domains induces significant conformational changes in the Het-S N-terminal HeLo domain.
  • This rearrangement exposes a transmembrane helix within Het-S.
  • Oligomerization of these helices leads to pore formation, cytosolic leakage, and cell death.

Conclusions:

  • The [Het-s] prion orchestrates programmed cytotoxicity by inducing a conformational change in Het-S, compromising membrane integrity.
  • This mechanism expands the known functions of amyloid proteins beyond simple aggregation.
  • The cell-killing mechanism may share similarities with pathological amyloid-induced tissue demise.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...